Correct Answer: A. Diphenylmethane
Diphenylmethane derivatives (e.g., bisacodyl, phenolphthalein) are laxatives, not prokinetics. They work by stimulating colonic smooth muscle contraction and increasing intestinal fluid secretion, producing a bowel movement—a cathartic effect. Prokinetics enhance gastric emptying and intestinal transit by promoting coordinated muscle contractions via neurochemical pathways (acetylcholine, serotonin, motilin). Diphenylmethanes bypass these physiological mechanisms and act as irritant/stimulant laxatives. In Indian clinical practice, bisacodyl is commonly prescribed for constipation management, but it is classified as a laxative in the pharmacological taxonomy, not a prokinetic. The key discriminator is mechanism: prokinetics restore or enhance normal GIT motility patterns; laxatives force evacuation. This is a fundamental classification error that NBE exploits by grouping a laxative among true prokinetic agents.
Why the other options are wrong
B. 5HT4 agonist — 5HT4 agonists (e.g., domperidone, metoclopramide at higher doses, prucalopride) are true prokinetics. They enhance acetylcholine release in the enteric nervous system, promoting coordinated antral contractions and gastric emptying. Domperidone is the first-line prokinetic in India for GERD and functional dyspepsia. This is a correct prokinetic class. C. Dopamine antagonist — Dopamine antagonists (metoclopramide, domperidone) are established prokinetics. They block dopamine inhibition of acetylcholine release, enhancing gastric smooth muscle contraction. Metoclopramide is widely used in Indian hospitals for postoperative nausea and gastric stasis. This is a correct prokinetic mechanism. D. Motilin — Motilin is an endogenous hormone that acts as a prokinetic by triggering phase III (migrating motor complex) contractions in the small intestine during fasting. Motilin agonists (domperidone has motilin-like activity) enhance gastric and intestinal motility. This is a correct prokinetic pathway.
High-Yield Facts
- Diphenylmethanes (bisacodyl, phenolphthalein) are stimulant laxatives, not prokinetics—they force bowel evacuation, not restore motility.
- 5HT4 agonists (domperidone, prucalopride) enhance acetylcholine release and are first-line prokinetics in India for dyspepsia.
- Dopamine antagonists (metoclopramide, domperidone) block inhibitory dopamine and promote gastric emptying—dual mechanism prokinetics.
- Motilin agonists trigger migrating motor complexes (MMC) in fasting state—endogenous prokinetic pathway.
- Prokinetics restore physiological motility patterns; laxatives bypass them via irritant or osmotic mechanisms.
Mnemonics
PROKINETICS vs LAXATIVES PRO = Promote normal motility (5HT4, dopamine antagonists, motilin). LAX = Laxatives force evacuation (diphenylmethanes, osmotic, bulk). Use this when differentiating drug classes in GIT pharmacology. Domperidone's Triple Action Dopamine antagonist + 5HT4 agonist + Motilin-like activity = Indian first-line prokinetic. Remember: one drug, three prokinetic mechanisms.
NBE Trap
NBE groups a laxative (diphenylmethane) among true prokinetic agents to test whether students confuse mechanism of action (laxatives force evacuation; prokinetics restore motility) with clinical effect (both increase bowel movement). Students unfamiliar with the pharmacological classification of bisacodyl often mistake it for a prokinetic.
Clinical Pearl
In Indian outpatient practice, when a patient with functional dyspepsia asks for a "bowel-moving medicine," the clinician must distinguish: domperidone restores normal stomach emptying (prokinetic), while bisacodyl forces colonic evacuation (laxative). Prescribing bisacodyl for dyspepsia is ineffective and may worsen symptoms by causing cramping without addressing gastric stasis.
_Reference: KD Tripathi Pharmacology Ch. 47 (GIT Drugs); Harrison Ch. 40 (Nausea, Vomiting, Dyspepsia)_